Hyperoxaluria clinical trials at UCSF

2 in progress, 1 open to eligible people

Hyperoxaluria is a condition where too much oxalate is in the urine. UCSF is studying a treatment called DCR-PHXC for people with severe kidney problems due to hyperoxaluria. This includes patients with PH1 or PH2, whether they are on dialysis or not.

Showing trials for

  • DCR-PHXC in Patients With PH1 and ESRD

    open to all eligible people

    The aim of this study is to evaluate DCR-PHXC in participants with PH1 and severe renal impairment, with or without dialysis.

    San Francisco, California and other locations

  • Long Term Extension Study in Patients With Primary Hyperoxaluria

    Sorry, accepting new patients by invitation only

    The proposed study is designed to provide patients previously enrolled in Phase 1 and 2 studies of DCR-PHXC and their siblings (<18 years old) long-term access to DCR-PHXC, and to evaluate the long-term safety and efficacy of DCR-PHXC in patients with PH.

    San Francisco, California and other locations

Last updated: